Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer.

Autor: Stein-Thoeringer CK; Laboratory of Translational Microbiome Science, Internal Medicine I, University Clinic Tuebingen, Germany.; CMFI Cluster of Excellence, University of Tuebingen, Germany.; DZIF (Deut. Zentrum für Infektionsforschung), HAARBI Partner Site Tuebingen, Germany., Renz BW; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, of the German Cancer Research Center (DKFZ), Heidelberg, Germany., De Castilhos J; Laboratory of Translational Microbiome Science, Internal Medicine I, University Clinic Tuebingen, Germany., von Ehrlich-Treuenstätt V; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Wirth U; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Tschaidse T; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Hofmann FO; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Koch DT; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Beirith I; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Ormanns S; German Cancer Consortium (DKTK), Partner Site Munich, of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany., Guba MO; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Angele MK; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Andrassy J; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Niess H; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., D'Haese JG; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany., Werner J; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Ilmer M; Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich, Ludwig-Maximilians-University Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, of the German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publikováno v: Annals of surgery [Ann Surg] 2024 Jan 26. Date of Electronic Publication: 2024 Jan 26.

IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells.

Autor: Heinen A; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Nederlof R; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Panjwani P; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Spychala A; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Tschaidse T; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Reffelt H; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Boy J; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Raupach A; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Gödecke S; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Petzsch P; Biologisch-Medizinisches Forschungszentrum (BMFZ), Genomics and Transcriptomics Labor, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Köhrer K; Biologisch-Medizinisches Forschungszentrum (BMFZ), Genomics and Transcriptomics Labor, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Grandoch M; Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Petz A; Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Fischer JW; Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Alter C; Institut für Molekulare Kardiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Vasilevska J; Institut für Molekulare Medizin II, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Lang P; Institut für Molekulare Medizin II, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany., Gödecke A; Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: axel.goedecke@uni-duesseldorf.de.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2019 Jan 02; Vol. 27 (1), pp. 46-58. Date of Electronic Publication: 2018 Nov 01.

PAPP-A-Specific IGFBP-4 Proteolysis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Autor: Adasheva, Daria A.¹ (AUTHOR), Lebedeva, Olga S.² (AUTHOR), Goliusova, Daria V.² (AUTHOR), Postnikov, Alexander B.³ (AUTHOR), Teriakova, Maria V.² (AUTHOR), Kopylova, Irina V.² (AUTHOR), Lagarkova, Maria A.² (AUTHOR), Katrukha, Alexey G.^1,3 (AUTHOR), Serebryanaya, Daria V.¹ (AUTHOR) serebryanaya@mail.bio.msu.ru

Publikováno v: International Journal of Molecular Sciences. May2023, Vol. 24 Issue 9, p8420. 14p.

Synergistic effects of hormones on structural and functional maturation of cardiomyocytes and implications for heart regeneration.

Autor: Galow, Anne-Marie, Brenmoehl, Julia, Hoeflich, Andreas

Publikováno v: Cellular & Molecular Life Sciences; Aug2023, Vol. 80 Issue 8, p1-33, 33p

Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction.

Autor: Nederlof, Rianne, Reidel, Sophia, Spychala, André, Gödecke, Stefanie, Heinen, André, Lautwein, Tobias, Petzsch, Patrick, Köhrer, Karl, Gödecke, Axel

Publikováno v: Frontiers in Immunology; 7/15/2022, Vol. 13, p1-16, 16p, 1 Chart, 6 Graphs